- Chuapoco, Miguel R;
- Flytzanis, Nicholas C;
- Goeden, Nick;
- Christopher Octeau, J;
- Roxas, Kristina M;
- Chan, Ken Y;
- Scherrer, Jon;
- Winchester, Janet;
- Blackburn, Roy J;
- Campos, Lillian J;
- Man, Kwun Nok Mimi;
- Sun, Junqing;
- Chen, Xinhong;
- Lefevre, Arthur;
- Singh, Vikram Pal;
- Arokiaraj, Cynthia M;
- Shay, Timothy F;
- Vendemiatti, Julia;
- Jang, Min J;
- Mich, John K;
- Bishaw, Yemeserach;
- Gore, Bryan B;
- Omstead, Victoria;
- Taskin, Naz;
- Weed, Natalie;
- Levi, Boaz P;
- Ting, Jonathan T;
- Miller, Cory T;
- Deverman, Benjamin E;
- Pickel, James;
- Tian, Lin;
- Fox, Andrew S;
- Gradinaru, Viviana
Crossing the blood-brain barrier in primates is a major obstacle for gene delivery to the brain. Adeno-associated viruses (AAVs) promise robust, non-invasive gene delivery from the bloodstream to the brain. However, unlike in rodents, few neurotropic AAVs efficiently cross the blood-brain barrier in non-human primates. Here we report on AAV.CAP-Mac, an engineered variant identified by screening in adult marmosets and newborn macaques, which has improved delivery efficiency in the brains of multiple non-human primate species: marmoset, rhesus macaque and green monkey. CAP-Mac is neuron biased in infant Old World primates, exhibits broad tropism in adult rhesus macaques and is vasculature biased in adult marmosets. We demonstrate applications of a single, intravenous dose of CAP-Mac to deliver functional GCaMP for ex vivo calcium imaging across multiple brain areas, or a cocktail of fluorescent reporters for Brainbow-like labelling throughout the macaque brain, circumventing the need for germline manipulations in Old World primates. As such, CAP-Mac is shown to have potential for non-invasive systemic gene transfer in the brains of non-human primates.